Gianluca Botticelli

Prof. Dr. Gianluca Botticelli


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2025 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
Gianluca BotticelliGianluca Botticelli
Gianluca Botticelli
Giovanni FalisiGiovanni Falisi
Giovanni Falisi
SRSofia Rastelli
Sofia Rastelli
EIEnzo Iacomino
Enzo Iacomino
ABAngelo Bruni
Angelo Bruni
Sara BernardiSara Bernardi
Sara Bernardi
Background: Peri-implantitis, the most prevalent cause of implant failure, is a multifaceted issue that is influenced by various factors that promote biofilm formation around the implant. Although various innovative methods for microbiological decontamination of dental implants exist, a universally accepted standard protocol has not yet been established. However, the potential of a device that generates an electric current (Ximplant®) in reducing the survival of microorganisms within the biofilm is a promising development. Methods: In this in vitro study, five dental implants, contaminated using a microbial culture from a sample of saliva of a patient suffering from peri-implantitis, were decontaminated using the Ximplant® peri-implantitis protocol. The experimental conditions included a simulated peri-implant site and a subsequent fluorescent assessment of the Live/Dead microbial population. Results: The qualitative and quantitative image analyses showed a predominant dead light signal on the treated sample, demonstrating the potential efficacy of applying the electrostatic field to the contaminated implant surface in reducing the viability of the microorganisms within the biofilm around dental implants. Conclusions: These findings could inspire a new era in peri-implantitis treatment.

27 August 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
DKDorian Kostandini
Dorian Kostandini
Antonella MatteiAntonella Mattei
Antonella Mattei
Giovanni FalisiGiovanni Falisi
Giovanni Falisi
AVArianna Viarchi
Arianna Viarchi
DGDavide Gerardi
Davide Gerardi
Gianluca BotticelliGianluca Botticelli
Gianluca Botticelli
Background: Treatment of peri-implantitis remains challenging because biofilm removal from microstructured implant surfaces is often incomplete. The present study is an uncontrolled, prospective feasibility case series involving six patients (six implants), not a controlled clinical trial, in which short-term clinical outcomes following use of a multimodal protocol to decontaminate the titanium implant surface were obtained; consequently, the independent contribution of the Ximplant® device to the observed outcomes cannot be determined. The protocol comprised surgical access, mechanical debridement, chemical conditioning, systemic administration of medication, and cleaning with an alternating-current device (Ximplant®; LED, S.p.A., Aprilia, Italy). Methods: Six adults with peri-implantitis, each contributing one implant, were consecutively treated using the multimodal protocol. Probing depth (PD), bleeding on probing (BOP), plaque index (PI), and suppuration (SU) were determined at baseline, 3 weeks, 6 months, and 12 months. Longitudinal changes were analyzed using repeated-measures analysis of variance and non-parametric tests for categorical variables. Results: Mean total PD decreased from 4.56 ± 0.45 mm at baseline to 3.03 ± 0.44 mm at the 3-week follow-up and remained stable at the 6-month follow-up (3.08 ± 0.35 mm) and at 12-month follow-up (3.19 ± 0.41 mm; p < 0.0001). BOP and SU were absent in all implants at each follow-up visit. PI improved markedly, although the buccal aspect of one implant was PI-positive at the 3-week and the 12-month follow-up. Conclusions: The multimodal protocol used in this study was associated with rapid and sustained clinical improvement over the 12-month follow-up period. A study limitation is that because the individual parts of the protocol were applied concurrently, the independent contribution of any of them to the outcomes determined could not be isolated.

16 April 2025 in Oral & Implantology
Verified
Journal Article
Open access
PDF file
EREduardo Basáñez Ribera
Eduardo Basáñez Ribera
RLRaymundo Ramírez Lugo
Raymundo Ramírez Lugo
RRRoberto Peña Ruiz
Roberto Peña Ruiz
BBBeatriz Aldape Barrios
Beatriz Aldape Barrios
Gianluca BotticelliGianluca Botticelli
Gianluca Botticelli
SMStefano Mummolo
Stefano Mummolo
The rehabilitation choice of patients undergoing resective surgery until some time ago was that of a removable prosthesis.With the introduction of implants and digitized programming, it is possible to perform previsualization of the surgical treatment and program all the various rehabilitation prosthetic phases.The authors present a case of a patient suffering from a giant cell lesion whose upper right jaw was surgically removed and then prosthetically rehabilitated. So, the only possibility we have of reducing the invasiveness of surgical treatments is to make an early diagnosis.

13 January 2026 in Journal of Stomatology Oral and Maxillofacial Surgery
Verified
Journal Article
Open access
DGDavide Gerardi
Davide Gerardi
PBPierangelo Burdo
Pierangelo Burdo
Gianluca BotticelliGianluca Botticelli
Gianluca Botticelli
DTDiana Torge
Diana Torge
FAFrancesca Angiolani
Francesca Angiolani
Varvara GiuseppeVarvara Giuseppe
Varvara Giuseppe
Ultrasound imaging is gaining increasing relevance in facial aesthetic medicine due to its real-time, non-invasive, and radiation-free nature. The purpose of this scoping review was to explore the clinical applications of ultrasonography in aesthetic medicine. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science to identify clinical studies evaluating the use of ultrasonography in facial aesthetic medicine. The search strategy included the following terms: "aesthetic", "facial", "ultrasound". PRISMA Extension for Scoping Review guidelines were used. A total of 6 studies were included in this review. Ultrasonography has been used to guide injections in facial aesthetic procedures such as filler and botulinum injection and to assess the thickness of the masseter muscle to evaluate the efficacy of masseter muscle hypertrophy treatment. Ultrasonography enhances the safety of facial aesthetic procedures by guiding injections into the correct tissue layers and minimizing vascular risks. Priority should be given to the development of standardized protocols and an increase in randomized clinical trials.

6 August 2026 in Prosthesis
Verified
Journal Article
Open access
PDF file
Gianluca BotticelliGianluca Botticelli
Gianluca Botticelli
AVArianna Viarchi
Arianna Viarchi
DGDavide Gerardi
Davide Gerardi
MSMarco Severino
Marco Severino
Antonella MatteiAntonella Mattei
Antonella Mattei
Giovanni FalisiGiovanni Falisi
Giovanni Falisi
Background: The management of complete mandibular edentulism in frail patients with severe bone atrophy is a clinical challenge. Ultrashort implants (≤4 mm) have been proposed as a minimally invasive alternative to bone augmentation procedures; however, long-term evidence in full-arch rehabilitations remains limited. Methods: This retrospective single-center cohort study presents the 10-year follow-up of patients treated with full-arch mandibular rehabilitation under immediate loading supported by 4 mm ultrashort implants. Patients were originally treated between 2015 and 2017. The primary outcome was prosthetic success at 10 years, defined as a stable and functional prosthesis supported by four implants. Secondary outcomes included implant survival, timing of implant loss, and biological and prosthetic complications. Results: Fourteen patients were available for evaluation at the 10-year follow-up. The success of the prosthetic structure was 100%, with all patients maintaining stable and functional rehabilitation. As regards the implants, a total of 82 implants had been placed, with 14 implant losses, resulting in a cumulative implant survival rate of 82.9%. Implant losses occurred mainly in early (1 week, 4 months) and late phases (between 3 and 10 years), while no losses were observed between 1 and 3 years. Overall, 71.43% of patients experienced at least one implant loss; however, this did not compromise prosthetic function. Conclusions: In this retrospective cohort, all full-arch prostheses remained functional at 10 years, although cumulative implant survival was 82.9%. These findings suggest that rehabilitation supported by 4 mm ultrashort implants may represent a treatment option for carefully selected frail patients with severe mandibular atrophy. Prospective controlled studies are needed to confirm these findings and compare this approach with standard-length implants and bone augmentation procedures.